The global market for Biobanks is estimated at US$76.5 Billion in 2023 and is projected to reach US$131.1 Billion by 2030, growing at a CAGR of 8.0% from 2023 to 2030. This comprehensive report provides an in-depth analysis of market trends, drivers, and forecasts, helping you make informed business decisions.
The growth in the biobank market is driven by several factors. Firstly, the increasing prevalence of chronic and complex diseases, such as cancer and cardiovascular disorders, is driving the demand for biobanks to support research into new treatments and diagnostics. Secondly, the rise of personalized medicine and precision healthcare is boosting the need for well-characterized biological samples that can be used to develop targeted therapies and interventions. Thirdly, the growing focus on genetic and genomic research is expanding the use of biobank samples for studying the genetic basis of diseases and identifying novel biomarkers.
Additionally, advancements in biobanking technologies, including automated storage systems and advanced data management platforms, are enhancing the efficiency and capabilities of biobanks. Lastly, increased funding and collaboration between academic institutions, healthcare organizations, and industry players are supporting the establishment and expansion of biobanks, driving market growth and fostering innovation in biomedical research.
The growth in the biobank market is driven by several factors. Firstly, the increasing prevalence of chronic and complex diseases, such as cancer and cardiovascular disorders, is driving the demand for biobanks to support research into new treatments and diagnostics. Secondly, the rise of personalized medicine and precision healthcare is boosting the need for well-characterized biological samples that can be used to develop targeted therapies and interventions. Thirdly, the growing focus on genetic and genomic research is expanding the use of biobank samples for studying the genetic basis of diseases and identifying novel biomarkers.
Additionally, advancements in biobanking technologies, including automated storage systems and advanced data management platforms, are enhancing the efficiency and capabilities of biobanks. Lastly, increased funding and collaboration between academic institutions, healthcare organizations, and industry players are supporting the establishment and expansion of biobanks, driving market growth and fostering innovation in biomedical research.
Key Insights:
- Market Growth: Understand the significant growth trajectory of the Physical / Real Biobanks segment, which is expected to reach US$99.2 Billion by 2030 with a CAGR of a 7.6%. The Virtual Biobanks segment is also set to grow at 9.5% CAGR over the analysis period.
- Regional Analysis: Gain insights into the U.S. market, estimated at $27.1 Billion in 2023, and China, forecasted to grow at an impressive 9.1% CAGR to reach $15.1 Billion by 2030. Discover growth trends in other key regions, including Japan, Canada, Germany, and the Asia-Pacific.
Why You Should Buy This Report:
- Detailed Market Analysis: Access a thorough analysis of the Global Biobanks Market, covering all major geographic regions and market segments.
- Competitive Insights: Get an overview of the competitive landscape, including the market presence of major players across different geographies.
- Future Trends and Drivers: Understand the key trends and drivers shaping the future of the Global Biobanks Market.
- Actionable Insights: Benefit from actionable insights that can help you identify new revenue opportunities and make strategic business decisions.
Key Questions Answered:
- How is the Global Biobanks Market expected to evolve by 2030?
- What are the main drivers and restraints affecting the market?
- Which market segments will grow the most over the forecast period?
- How will market shares for different regions and segments change by 2030?
- Who are the leading players in the market, and what are their prospects?
Report Features:
- Comprehensive Market Data: Independent analysis of annual sales and market forecasts in US$ Million from 2023 to 2030.
- In-Depth Regional Analysis: Detailed insights into key markets, including the U.S., China, Japan, Canada, Europe, Asia-Pacific, Latin America, Middle East, and Africa.
- Company Profiles: Coverage of major players such as AMS Biotechnology (Europe) Limited, Bay Biosciences LLC, BioIVT & Elevating Science, and more.
- Complimentary Updates: Receive free report updates for one year to keep you informed of the latest market developments.
Select Competitors (Total 99 Featured):
- AMS Biotechnology (Europe) Limited
- Bay Biosciences LLC
- BioIVT & Elevating Science
- BioLifeSolutions Inc.
- Biovault Technical
- CENTOGENE NV
- CTI Biotech
- Cureline, Inc.
- Firalis S.A.
- Hamilton Company
- Merck KGaA
- ProteoGenex, Inc.
- Tecan Trading AG
- Thermo Fisher Scientific Inc.
- US Biolab Corporation, Inc.
- VWR International LLC
Table of Contents
I. METHODOLOGYII. EXECUTIVE SUMMARY2. FOCUS ON SELECT PLAYERSIII. MARKET ANALYSISCANADAJAPANFRANCEGERMANYITALYUNITED KINGDOMREST OF EUROPEREST OF WORLDIV. COMPETITION
1. MARKET OVERVIEW
3. MARKET TRENDS & DRIVERS
4. GLOBAL MARKET PERSPECTIVE
UNITED STATES
CHINA
EUROPE
ASIA-PACIFIC
Companies Mentioned
- AMS Biotechnology (Europe) Limited
- Bay Biosciences LLC
- BioIVT & Elevating Science
- BioLifeSolutions Inc.
- Biovault Technical
- CENTOGENE NV
- CTI Biotech
- Cureline, Inc.
- Firalis S.A.
- Hamilton Company
- Merck KGaA
- ProteoGenex, Inc.
- Tecan Trading AG
- Thermo Fisher Scientific Inc.
- US Biolab Corporation, Inc.
- VWR International LLC
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 402 |
| Published | November 2024 |
| Forecast Period | 2023 - 2030 |
| Estimated Market Value ( USD | $ 76.5 Billion |
| Forecasted Market Value ( USD | $ 131.1 Billion |
| Compound Annual Growth Rate | 8.0% |
| Regions Covered | Global |
| No. of Companies Mentioned | 16 |
